The news is that they've 'accelerated' the timeline by pushing back commercialisation by a further 12 months.
That's assuming that the 18 month clinical phase which now appears to be 6 months doesn't also need adjustments further down the line.
No news would have been good news in this case I'm afraid.
Back in the bottom drawer for this one.
Ann: AGM Presentation, page-15
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.010(2.27%) |
Mkt cap ! $50.18M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.0¢ | 43.5¢ | $15.99K | 35.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 507 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 1925 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |